271 related articles for article (PubMed ID: 26064963)
21. Pathogenesis of respiratory syncytial virus infection in the murine model.
Peebles RS; Graham BS
Proc Am Thorac Soc; 2005; 2(2):110-5. PubMed ID: 16113477
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus.
Kawashima K; Meyerholz DK; Gallup JM; Grubor B; Lazic T; Lehmkuhl HD; Ackermann MR
Viral Immunol; 2006; 19(2):316-23. PubMed ID: 16817774
[TBL] [Abstract][Full Text] [Related]
23. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis.
García C; Soriano-Fallas A; Lozano J; Leos N; Gomez AM; Ramilo O; Mejias A
Pediatr Infect Dis J; 2012 Jan; 31(1):86-9. PubMed ID: 21829141
[TBL] [Abstract][Full Text] [Related]
24. Respiratory syncytial virus infection and immunity.
González PA; Bueno SM; Carreño LJ; Riedel CA; Kalergis AM
Rev Med Virol; 2012 Jul; 22(4):230-44. PubMed ID: 22290692
[TBL] [Abstract][Full Text] [Related]
25. Innate Immune Evasion by Human Respiratory RNA Viruses.
Kikkert M
J Innate Immun; 2020; 12(1):4-20. PubMed ID: 31610541
[TBL] [Abstract][Full Text] [Related]
26. Viral infections in asthma and COPD.
Matsumoto K; Inoue H
Respir Investig; 2014 Mar; 52(2):92-100. PubMed ID: 24636264
[TBL] [Abstract][Full Text] [Related]
27. NK cell immunophenotypic and genotypic analysis of infants with severe respiratory syncytial virus infection.
Noyola DE; Juárez-Vega G; Monjarás-Ávila C; Escalante-Padrón F; Rangel-Ramírez V; Cadena-Mota S; Monsiváis-Urenda A; García-Sepúlveda CA; González-Amaro R
Microbiol Immunol; 2015 Jul; 59(7):389-97. PubMed ID: 25988502
[TBL] [Abstract][Full Text] [Related]
28. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
[TBL] [Abstract][Full Text] [Related]
29. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
[TBL] [Abstract][Full Text] [Related]
30. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children.
Bermejo-Martin JF; Garcia-Arevalo MC; Alonso A; De Lejarazu RO; Pino M; Resino S; Tenorio A; Bernardo D; Leon AJ; Garrote JA; Ardura J; Dominguez-Gil M; Eiros JM; Blanco-Quiros A; Munoz-Fernandez MA; Kelvin DJ; Arranz E
J Allergy Clin Immunol; 2007 Jun; 119(6):1547-50. PubMed ID: 17451801
[No Abstract] [Full Text] [Related]
31. Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally.
Watanabe W; Shimizu T; Sawamura R; Hino A; Konno K; Kurokawa M
J Med Virol; 2010 May; 82(6):1075-82. PubMed ID: 20419825
[TBL] [Abstract][Full Text] [Related]
32. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma.
Hirose H; Matsuse H; Fukahori S; Tsuchida T; Tomari S; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int Arch Allergy Immunol; 2008; 147(3):197-205. PubMed ID: 18594149
[TBL] [Abstract][Full Text] [Related]
33. Similar cytokine profiles in response to infection with respiratory syncytial virus type a and type B in the upper respiratory tract in infants.
Bermejo-Martin JF; Tenorio A; Ortiz de Lejarazu R; Eiros JM; Matías V; Dominguez-Gil M; Pino M; Alonso A; Blanco-Quiros A; Arranz E; Ardura J
Intervirology; 2008; 51(2):112-5. PubMed ID: 18493154
[TBL] [Abstract][Full Text] [Related]
34. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
[TBL] [Abstract][Full Text] [Related]
35. In utero tobacco smoke exposure alters lung inflammation, viral clearance, and CD8
Cheemarla NR; Uche IK; McBride K; Naidu S; Guerrero-Plata A
Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L212-L221. PubMed ID: 31090436
[TBL] [Abstract][Full Text] [Related]
36. The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection.
Derscheid RJ; Ackermann MR
Vet Pathol; 2013 Sep; 50(5):827-41. PubMed ID: 23528938
[TBL] [Abstract][Full Text] [Related]
37. Equal virulence of rhinovirus and respiratory syncytial virus in infants hospitalized for lower respiratory tract infection.
Van Leeuwen JC; Goossens LK; Hendrix RM; Van Der Palen J; Lusthusz A; Thio BJ
Pediatr Infect Dis J; 2012 Jan; 31(1):84-6. PubMed ID: 21909047
[TBL] [Abstract][Full Text] [Related]
38. Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.
Jorquera PA; Anderson L; Tripp RA
Expert Rev Vaccines; 2016; 15(2):173-87. PubMed ID: 26641318
[TBL] [Abstract][Full Text] [Related]
39. Urokinase receptor-deficient mice mount an innate immune response to and clarify respiratory viruses as efficiently as wild-type mice.
Ramos M; Lao Y; Eguiluz C; Del Val M; Martínez I
Virulence; 2015; 6(7):710-5. PubMed ID: 26115163
[TBL] [Abstract][Full Text] [Related]
40. Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines.
Zeng R; Cui Y; Hai Y; Liu Y
Virus Res; 2012 Aug; 167(2):138-45. PubMed ID: 22698878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
